Efficacy & Toxicity
Target Validation
Toxicity Assays
Multi Cancer Screening

Aug 9 2021

CLIENT PUBLICATION

 

Congratulations to Prof Michael Lisanti, MD-PhD, FRSA, FRSB, FRSC and his collaborators for

this new publication !!

 

Through our technology, we have allowed many of our customers to get their first proof-of-concept

for in vivo activities of their innovative treatments.
This is always a very exciting moment, which opens new perspectives for their drug discovery projects.

 

Come see more examples of Inovotion customer publications!

 

Let’s discover together how INOVOTION can help you realize your projects.

 

If you are also interested in optimizing your preclinical drug discovery with our

innovative in vivo technology platform, please contact us for a free estimation!

All our news

All our webinars